Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jul 4, 2023
Open Peer Review Period: Jul 4, 2023 - Aug 29, 2023
Date Accepted: Jun 20, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A Patient-Driven Mobile Health Innovation in Cystic Fibrosis Care: Comparative Cross-Case Study

Mazzocato P, Luckhaus JL, Malmqvist Castillo M, Burnett J, Hager A, Oates G, Carolina Wannheden C, Savage C

A Patient-Driven Mobile Health Innovation in Cystic Fibrosis Care: Comparative Cross-Case Study

J Med Internet Res 2024;26:e50527

DOI: 10.2196/50527

PMID: 39083342

PMCID: 11325108

Patients cannot do it alone: A cross-case study of a patient-driven mHealth innovation in cystic fibrosis care

  • Pamela Mazzocato; 
  • Jamie Linnea Luckhaus; 
  • Moa Malmqvist Castillo; 
  • Johan Burnett; 
  • Andreas Hager; 
  • Gabriela Oates; 
  • Carolina Carolina Wannheden; 
  • Carl Savage

ABSTRACT

Background:

Patient-driven innovation in health care is an emerging phenomenon with benefits for patients with chronic conditions such as cystic fibrosis (CF). However, previous research has not examined what may facilitate or hinder implementation of such innovations from the provider perspective.

Objective:

The aim of this study was to explain variations in the adoption of a patient-driven innovation among CF clinics.

Methods:

An explanatory, multiple-case study on the adoption of a patient-controlled information app for the co-production of care that places the patient at the center of the decision-making process. Data collection and analysis were guided by the Non-adoption, Abandonment, Spread, Scale-up, and Sustainability framework and Complexity Assessment Tool (NASSS-CAT). Data included user-activity levels of patients and qualitative interviews with staff at nine clinics (eight in Sweden, one in the USA). We performed a statistical process control (SPC) analysis of user-activity data. Qualitative data was subjected to content analysis, a complexity analysis, and used to generate process maps. All data was then triangulated in a cross-case analysis.

Results:

We grouped clinics into high, middle, and low adoption clusters based on patient user-activity levels. Higher perceived complexity by providers was associated with lower adoption. Research on the innovation and new features positively impacted adoption. Early adoption and a champion-reliant adoption process negatively impacted sustainability.

Conclusions:

Health care providers played a significant role in the adoption of the patient-driven innovation. Providers who worked to reduce variation in care processes reported a lower level of perceived complexity, and developed co-ownership of the innovation through research, patient training, and a team effort to integrate the innovation into existing care processes. These clinics demonstrated a higher capability to support the adoption and sustainability of innovative ideas developed by patients. For patient-driven innovations to be adopted and sustained in health care, understanding patient-provider interdependency and perspectives on what generates value is essential.


 Citation

Please cite as:

Mazzocato P, Luckhaus JL, Malmqvist Castillo M, Burnett J, Hager A, Oates G, Carolina Wannheden C, Savage C

A Patient-Driven Mobile Health Innovation in Cystic Fibrosis Care: Comparative Cross-Case Study

J Med Internet Res 2024;26:e50527

DOI: 10.2196/50527

PMID: 39083342

PMCID: 11325108

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.